Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
20 Feb 2026
GLP-1 Receptor Agonists Linked to Lower Dementia Risk in CKD
GLP-1 receptor agonists were associated with lower dementia and Alzheimer’s risk in patients with type 2 diabetes and CKD stage 3 or later.
9
Mins
20 Feb 2026
Why Point of Care Ultrasound Is More than the Modern Rheumatologist’s Stethoscope
Ultrasound (US) is a very helpful clinical tool in rheumatology due to its low cost, portability, and accessibility for point of…
20 Feb 2026
Few GLP 1 Studies Report Dietary Outcomes
A review of 41 trials finds only two assessed dietary intake with GLP 1 receptor agonists, underscoring a critical gap in nutrition research.
20 Feb 2026
Elenagen Combination Extends Survival in Ovarian Cancer
Phase two data show Elenagen combined with gemcitabine significantly prolongs overall survival in platinum resistant ovarian cancer without added safety concerns.
20 Feb 2026
Salvage Focal Therapy Matches Surgery in Radiorecurrent PCa
Salvage focal therapy delivers similar 10-year survival to surgery in radiorecurrent prostate cancer, with significantly fewer perioperative complications.
20 Feb 2026
Apple Watch Improves Detection of Atrial Fibrillation, Study Shows
Smartwatch monitoring significantly improves atrial fibrillation detection, enabling earlier diagnosis and strengthening prevention strategies in high risk patients.
20 Feb 2026
Cesarean Delivery Linked to Postmolar Neoplasia Risk
Prior cesarean delivery was linked to higher postmolar gestational trophoblastic neoplasia risk, without increased chemoresistance overall.
20 Feb 2026
Hepta Refractory Multiple Myeloma Shows Genomic Complexity
Hepta refractory multiple myeloma is characterised by antigen loss, complex genomic alterations, and poor survival, with limited benefit from successive salvage therapies.
20 Feb 2026
Dysphonia After Spinal Cord Injury: What Helps
Systematic review outlines diagnosis and rehabilitation for dysphonia after spinal cord injury noting key tools and remaining gaps.
20 Feb 2026
Onc Now: Rethinking Head and Neck Cancer
: In this episode of Onc Now, Kevin Harrington discusses the evolving landscape of head and neck cancer treatment, from the transformative…
←
1
2
3
…
12
13
14
15
16
17
18
…
1,504
1,505
1,506
→
We’ve noticed you’re accessing
from
North/South America.
View
View